|
CFLAR expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.213100E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.264000E-03 |
| Normal-vs-Stage2 |
9.17239999509434E-08 |
| Normal-vs-Stage3 |
4.966600E-04 |
| Normal-vs-Stage4 |
5.022200E-03 |
| Stage1-vs-Stage2 |
2.33839999996821E-06 |
| Stage1-vs-Stage3 |
2.059000E-01 |
| Stage1-vs-Stage4 |
7.656000E-01 |
| Stage2-vs-Stage3 |
1.520340E-03 |
| Stage2-vs-Stage4 |
8.836300E-04 |
| Stage3-vs-Stage4 |
5.134600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.779400E-03 |
| Normal-vs-AfricanAmerican |
1.059570E-01 |
| Normal-vs-Asian |
1.295800E-02 |
| Caucasian-vs-AfricanAmerican |
5.766000E-01 |
| Caucasian-vs-Asian |
7.451400E-01 |
| AfricanAmerican-vs-Asian |
7.946200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.95489999999766E-05 |
| Normal-vs-Female |
1.317700E-03 |
| Male-vs-Female |
6.311800E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.504250E-02 |
| Normal-vs-Age(41-60Yrs) |
2.991900E-04 |
| Normal-vs-Age(61-80Yrs) |
2.19349999996954E-06 |
| Normal-vs-Age(81-100Yrs) |
1.772770E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.420600E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.88139999996095E-06 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.384000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.045700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.895200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.790780E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.953200E-01 |
| Classical-VS-Follicular |
1.11022302462516E-16 |
| Classical-VS-Other |
2.939600E-01 |
| Classical-VS-Normal |
1.482100E-02 |
| Tall-VS-Follicular |
5.67869973266966E-10 |
| Tall-VS-Other |
1.758390E-01 |
| Tall-VS-Normal |
4.125700E-02 |
| Follicular-VS-Other |
5.421700E-02 |
| Follicular-VS-Normal |
8.66840044189132E-10 |
| Other-VS-Normal |
9.321700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.02569999996349E-06 |
| Normal-vs-N1 |
2.414300E-02 |
| N0-vs-N1 |
9.382700E-04 |
|
|
